[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100634713":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":20,"locations":26,"responsibleParty":42,"collaborators":44,"id":64,"slug":65,"hasResults":66,"nctId":67,"briefTitle":68,"officialTitle":68,"acronym":10,"eligibilityCriteria":69,"healthyVolunteers":66,"sex":70,"minAge":71,"maxAge":10,"enrollmentInfo":72,"targetDuration":10,"studyType":75,"phases":10,"briefSummary":76,"conditions":77,"keywords":79,"overallStatus":83,"whyStopped":10,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":93},{"fullName":5,"class":6},"Qilu Hospital of Shandong University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients undergoing EUS",null,"Patients aged ≥18 years scheduled for EUS with suspected pancreatic cystic lesions based on clinical symptoms, medical history, laboratory tests or radiological examinations are eligible upon agreement to participate in the research and voluntary signing of the informed consent.",[13],"Device: iEUS-PCL(intelligent endoscopic ultrasound system- pancreatic cystic lesion)",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DEVICE","iEUS-PCL(intelligent endoscopic ultrasound system- pancreatic cystic lesion)","The iEUS-PCL will automatically detect pancreatic cystic lesions and integrate the patients' EUS images, EUS features, clinical data and radiological imaging features to perform three classification tasks:\n\n1. binary classification: benign\u002Fmalignant lesions;\n2. binary classification: mucinous\u002Fnon-mucinous lesions;\n3. four-category classification: intraductal papillary mucinous neoplasm\u002F mucinous cystic neoplasm\u002F serous cyst neoplasm\u002F pancreatic cyst.",[9],[21],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},"Zhen Li","CONTACT","86+18560086106","qilulizhen@sdu.edu.cn",[27],{"facility":5,"status":10,"city":28,"state":29,"zip":30,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"Jinan","Shandong","250012","China","CN",{"type":34,"coordinates":35},"Point",[36,37],116.99722,36.66833,{"lat":37,"lon":36},[40],{"name":41,"role":23,"phone":24,"phoneExt":10,"email":25},"Zhen Li, doctor",{"type":43,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[45,47,49,51,53,56,58,60,62],{"name":46,"class":6},"Liaocheng People's Hospital",{"name":48,"class":6},"Taian City Central Hospital",{"name":50,"class":6},"Qilu Hospital of Shandong University (Qingdao)",{"name":52,"class":6},"Binzhou People's Hospital",{"name":54,"class":55},"Shandong Provincial Hospital","OTHER_GOV",{"name":57,"class":6},"The Affiliated Hospital of Qingdao University",{"name":59,"class":6},"Qianfoshan Hospital",{"name":61,"class":6},"Shengli Oilfield Hospital",{"name":63,"class":6},"Binzhou Medical University","100634713","an-artificial-intelligence-system-for-multimodal-multi-class-diagnosis-of-pancreatic-cystic-lesions-based-on-endoscopic-ultrasonography-100634713",false,"NCT07543263","An Artificial Intelligence System for Multimodal, Multi-class Diagnosis of Pancreatic Cystic Lesions Based on Endoscopic Ultrasonography","Inclusion Criteria:\n\n\\- 1. Patients aged ≥18 years scheduled for EUS with suspected pancreatic cystic lesions based on clinical symptoms, medical history, laboratory tests or radiological examinations, and who agree to participate in the research and voluntarily sign the informed consent.\n\n2\\. Patients with no prior history of treatment for pancreatic lesions.\n\nExclusion Criteria:\n\n\\- 1. Patients with absolute contraindications to EUS examination. 2. Pregnancy or lactating. 3. Uncorrectable coagulopathy(PTT\\>50 seconds or INR\\>1.5) and\u002For uncorrectable thrombocytopenia(platelet count\\\u003C50×109\u002FL). 4. Upper gastrointestinal obstruction. 5. Patients who underwent surgical treatment or anatomical alterations of the pancreas due to lesions in other thoracic and\u002For abdominal organs, as well as patients with congenital anatomical abnormalities.\n\n6\\. Patients who have undergone biliary\u002Fpancreatic duct stent placement. 7. Patients who refuse to sign the informed consent.","ALL","18 Years",{"count":73,"type":74},176,"ESTIMATED","OBSERVATIONAL","The aim of this study is to develop and validate an artificial intelligence system named iEUS-PCL (intelligent endoscopic ultrasound system-pancreatic cystic lesions） for detecting and multimodal, multi-class diagnosing pancreatic cystic lesions (PCL) during endoscopic ultrasound (EUS) examination.",[78],"Pancreatic Cystic Lesion (PCL)",[80,81,82],"endoscopic ultrasound","pancreatic cystic lesion","machine learning","NOT_YET_RECRUITING","2026-04-23",{"date":86,"type":87},"2026-04-29","ACTUAL",{"date":89,"type":74},"2026-04-20",{"date":91,"type":74},"2028-06-30",{"name":5,"class":6},1]